Filing Details

Accession Number:
0001415889-23-017015
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-29 16:30:19
Reporting Period:
2023-12-28
Accepted Time:
2023-12-29 16:30:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1468316 Rosty Raykov C/O Fennec Pharmaceuticals, Inc.
Po Box 13628, 68 Tw Alexander Drive
Research Triangle Park NC 27709
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2023-12-28 8,540 $1.59 291,127 No 4 M Direct
Common Shares Disposition 2023-12-28 3,656 $11.55 287,471 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Options Commons Shares Acquisiton 2023-12-28 8,540 $1.59 8,540 $1.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
271,784 2014-01-24 2024-01-24 No 4 M Direct
Footnotes
  1. Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.
  2. Shares sold to satisfy tax obligation on option exercise.
  3. Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.